研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

[综合和补充疗法的使用率与慢性病:2019年全国健康调查]。

[Prevalence of the use of integrative and complementary practices and chronic diseases: 2019 National Health Survey].

发表日期:2024 Sep
作者: Mário Círio Nogueira, Ana Carolina Moreira Bicalho, Ana Flávia Côrrea Magalhães, Julia Barroso Marques Martins, Marcella Barroso Marques Martins
来源: Arthritis & Rheumatology

摘要:

该研究旨在调查巴西成年人群中患有慢性疾病或病症与采用综合补充疗法 (ICP) 的流行率之间的关系。慢性病是一个严重的公共卫生问题,西医在提供有效答案方面存在局限性。因此,对 ICP 的需求有所增加,因为它们构成了一种人性化的治疗选择,成本低廉且易于获取。使用 2019 年全国健康调查的数据进行了一项基于人群的横断面研究。 ICP使用的流行率是根据其他变量的类别(是否存在慢性病)来估计的,流行率(PR)根据社会人口统计学变量进行了调整。在过去 12 个月中,巴西成年人口(18 岁及以上)使用特定 ICP 的比例为 5.5%(95%CI:5.2%-5.8%),患有慢性病的成年人即使在调整了社会人口统计特征后,其使用率也较高(PR:2.11;95%CI:1.89-2.36)。中风、哮喘、关节炎、与工作相关的肌肉骨骼疾病、抑郁症和其他精神疾病、慢性阻塞性肺病、癌症和高血压等心脏病与 ICP 使用率较高有关。
The study sought to investigate the association between having a chronic disease or condition and the prevalence of having recourse to Integrative and Complementary Practices (ICP) among the Brazilian adult population. Chronic diseases are a serious public health issue and there are limitations of Western medicine to offer effective answers. Thus, the demand for ICP has increased as they constitute a humanized treatment option, with low cost and ease of acquisition. A cross-sectional population-based study was carried out using data from the 2019 National Health Survey. The prevalence of ICP use was estimated by categories of the other variables (presence or absence of chronic conditions) and prevalence ratios (PR) were adjusted for sociodemographic variables. The prevalence of the use of a given ICP, in the last 12 months, by the adult Brazilian population (18 years of age and over) was 5.5% (95%CI: 5.2%-5.8%), and adults with a chronic condition had a higher prevalence of use (PR: 2.11; 95%CI: 1.89-2.36), even after adjusting for sociodemographic characteristics. Stroke, asthma, arthritis, work-related musculoskeletal disorders, depression and other mental illnesses, chronic obstructive pulmonary disease, cancer and heart disease such as hypertension were associated with a higher prevalence of ICP use.